Close

Dr Edward Parker

BA MSc PhD

Research Fellow
in Systems Biology

Room
490

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

I completed a BA in Biological Sciences at Oxford University, an MSc in Laboratory Medicine at the University of Toronto, and a PhD in infectious disease epidemiology at Imperial College London.

Affiliations

Department of Clinical Research
Faculty of Infectious and Tropical Diseases

Centres

Vaccine Centre

Research

My work considers factors that drive variation in response to vaccines. To date, I have focused on the possible contribution of the microbiome to this phenomenon, applying a range of lab and bioinformatic tools to sequence gut bacteria and viruses among infants receiveing oral vaccines in low-income countries.

I am interested in data visualisation, and led the development of an interactive mapping tool to help contextualise the COVID-19 outbreak as well as LSHTM's COVID-19 vaccine tracker, which launched in April 2020. In late 2021, I acted as a consultant for the COVID-19 Working Group of the WHO's Strategic Advisory Group of Experts on Immunization.

I am currently undertaking a UKRI/MRC COVID-19 secondment, working with LSHTM's Electronic Health Records group and the University of Oxford's Bennett Institute for Applied Data Science to explore variation in COVID-19 vaccine response in immunocompromised populations in the UK.

Popular science writing:

A rise in deaths from preventable diseases must not be part of Covid-19's legacy, The Guardian, April 2020

Coronavirus: who is at risk and how do we know? The Conversation, March 2020 (co-authored with Professor Beate Kampmann)

Coronavirus outbreak: a new mapping tool that lets you scroll through timeline, The Conversation, February 2020

Andy Serkis’s Breathe is a haunting reminder of the pre-vaccine era, The Conversation, October 2017 (reprinted by The Independent)

Salk's swansong: renaissance of the injected polio vaccine, Science-based Medicine, October 2014

Sister Kenny: a study in inflexibility, The Lancet Infectious Diseases, June 2014

Research Area
Systematic reviews
Vaccines
Immunisation
Discipline
Immunology
Microbiology
Bioinformatics
Vaccinology
Disease and Health Conditions
Diarrhoeal diseases
Infectious disease
Country
The Gambia
India
Malawi
Region
South Asia
Sub-Saharan Africa (developing only)

Selected Publications

Waning effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines over six months since second dose: a cohort study using linked electronic health records
Horne EMF; Hulme W; Keogh R; Palmer T; Williamson E; Parker EPK; Green A; Walker V; Walker A; Curtis H
2022
medRxiv
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records.
Horne EMF; Hulme WJ; Keogh RH; Palmer TM; Williamson EJ; Parker EPK; Green A; Walker V; Walker AJ; Curtis H
2022
British Medical Journal
Comparative effectiveness of BNT162b2 versus mRNA-1273 boosting in England: a cohort study in OpenSAFELY-TPP
Hulme W; Horne EMF; Parker EPK; Keogh R; Williamson E; Walker V; Palmer T; Curtis H; Walker A; Mehrkar A
2022
medRxiv
Effectiveness of BNT162b2 booster doses in England: an observational study in OpenSAFELY-TPP
Hulme W; Williamson E; Horne E; Green A; Nab L; Keogh R; Parker EPK; Walker V; Palmer T; Curtis H
2022
medRxiv
Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study
Parker EPK; Horne EMF; Hulme WJ; Tazare J; Zheng B; Carr EJ; Loud F; Lyon S; Mahalingasivam V; MacKenna B
2022
Cold Spring Harbor Laboratory
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study
The OpenSAFELY Collaborative; Parker EPK; Tazare J; Hulme W; Bates C; Beale R; Carr E; Cockburn J; Curtis H; Fisher L
2022
medRxiv
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform.
Zheng B; Green ACA; Tazare J; Curtis HJ; Fisher L; Nab L; Schultze A; Mahalingasivam V; Parker EPK; Hulme WJ
2022
BMJ (Clinical research ed.)
See more Publications